<!DOCTYPE html>
<html >

<head>

  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정</title>
  <meta name="description" content="Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정">
  <meta name="generator" content="bookdown 0.5.9 and GitBook 2.6.7">

  <meta property="og:title" content="Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정" />
  <meta property="og:type" content="book" />
  
  
  
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정" />
  
  
  

<meta name="author" content="Sungpil Han">


<meta name="date" content="2017-11-16">

  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black">
  
  


<script src="libs/jquery-2.2.3/jquery.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />










<link rel="stylesheet" href="css\style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li class="chapter" data-level="1" data-path=""><a href="#intro"><i class="fa fa-check"></i><b>1</b> 서론</a><ul>
<li class="chapter" data-level="1.1" data-path=""><a href="#fda"><i class="fa fa-check"></i><b>1.1</b> FDA</a></li>
<li class="chapter" data-level="1.2" data-path=""><a href="#emea"><i class="fa fa-check"></i><b>1.2</b> EMEA</a></li>
<li class="chapter" data-level="1.3" data-path=""><a href="#pmda"><i class="fa fa-check"></i><b>1.3</b> PMDA</a></li>
</ul></li>
<li class="chapter" data-level="2" data-path=""><a href="#modeling-and-simulation-"><i class="fa fa-check"></i><b>2</b> Modeling and Simulation 관련규정</a><ul>
<li class="chapter" data-level="2.1" data-path=""><a href="#fda-1"><i class="fa fa-check"></i><b>2.1</b> FDA</a><ul>
<li class="chapter" data-level="2.1.1" data-path=""><a href="#section-2.1.1"><i class="fa fa-check"></i><b>2.1.1</b> 일반론</a></li>
<li class="chapter" data-level="2.1.2" data-path=""><a href="#section-2.1.2"><i class="fa fa-check"></i><b>2.1.2</b> 소아</a></li>
</ul></li>
<li class="chapter" data-level="2.2" data-path=""><a href="#emea-1"><i class="fa fa-check"></i><b>2.2</b> EMEA</a></li>
<li class="chapter" data-level="2.3" data-path=""><a href="#pmda-1"><i class="fa fa-check"></i><b>2.3</b> PMDA</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path=""><a href="#ref"><i class="fa fa-check"></i><b>3</b> 참고문헌</a></li>
</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="header">
<h1 class="title">Modeling and Simulation을 이용한 Special population에서의 약물 인허가 현황과 관련규정</h1>
<h4 class="author"><em>Sungpil Han</em></h4>
<h4 class="date"><em>2017-11-16</em></h4>
</div>
<div id="intro" class="section level1">
<h1><span class="header-section-number">1</span> 서론</h1>
<p>모델링과 시뮬레이션을 사용하면 특수 집단에서의 약물 사용에 큰 도움을 줄 수 있다. 장점을 기술. <span class="citation">(R Core Team <a href="#ref-R-base">2017</a>)</span></p>
<ul>
<li>안전성을 확보</li>
<li>적절한 용량의 사용 가능</li>
<li>부작용 발생 시 빠른 대처 가능</li>
<li>비용 절감</li>
</ul>
<div id="fda" class="section level2">
<h2><span class="header-section-number">1.1</span> FDA</h2>
<p>Mehrotra의 서론 부분을 요약.</p>
<p>에소메프라졸을 소아에서 GERD 치료시 사용. <span class="citation">(Mehrotra et al. <a href="#ref-Mehrotra_2016">2016</a>)</span></p>
<ul>
<li>Esomeprazole in Pediatrics for the Treatment of Gastroesophageal Reflux Disease with Erosive Esophagitis: Intravenous Dose Selection <span class="citation">(Mehrotra et al. <a href="#ref-Mehrotra_2016">2016</a>)</span></li>
<li>Approval of Vigabatrin for Refractory Complex Partial Seizures in Pediatrics (Mehrotra, 2016, Drug Metabolism and Disposition)</li>
<li>Adalimumab: Crohn’s Disease in Children: Dose Selection (Mehrotra, 2016, Drug Metabolism and Disposition)</li>
<li>Darunavir : Exposure-Response and PK Matching to Bridge Dosing for Different Patient Populations in Pediatrics for the Treatment of Human Immunodeficiency Virus (Mehrotra, 2016, Drug Metabolism and Disposition)</li>
<li>Topiramate: Topiramate Dosing Regimen was Derived by Matching Steady State Trough Concentrations (CMIN) for Different Age Groups</li>
<li>Pralidoxime: Derived and recommended Pediatric Dosing Recommendations without any empirical data</li>
<li>Peramivir: Derived and recommended Pediatric Dosing Recommendations without any empirical data</li>
</ul>
</div>
<div id="emea" class="section level2">
<h2><span class="header-section-number">1.2</span> EMEA</h2>
<ul>
<li>2015년 EMEA MSWG (Modeling and Simulation Working Group)에 의뢰된 관련 업무의 사례 수 (Figure 1)</li>
</ul>
<!--[2015년 EMEA MSWG (Modeling and Simulation Working Group)에 의뢰된 관련 업무의 사례 수. Reference: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2017/03/WC500222778.pdf](assets/emea.png)-->
</div>
<div id="pmda" class="section level2">
<h2><span class="header-section-number">1.3</span> PMDA</h2>
<ul>
<li>2014년에서 2016년까지 PBPK를 사용한 17 개의 NDA 제출 (2017, Sato, CPT Pharmacometrics Syst. Pharmacol)</li>
</ul>
</div>
</div>
<div id="modeling-and-simulation-" class="section level1">
<h1><span class="header-section-number">2</span> Modeling and Simulation 관련규정</h1>
<div id="fda-1" class="section level2">
<h2><span class="header-section-number">2.1</span> FDA</h2>
<div id="section-2.1.1" class="section level3">
<h3><span class="header-section-number">2.1.1</span> 일반론</h3>
<ul>
<li>Guidance for Industry End-of-Phase 2A Meetings <a href="https://www.fda.gov/downloads/Drugs/.../Guidances/ucm079690.pdf" class="uri">https://www.fda.gov/downloads/Drugs/.../Guidances/ucm079690.pdf</a></li>
</ul>
</div>
<div id="section-2.1.2" class="section level3">
<h3><span class="header-section-number">2.1.2</span> 소아</h3>
<ul>
<li>1994, Pediatric Labeling Rule(Extrapolation Introduced)</li>
<li>1997, FDA Modernization Act (FDAMA) (Pediatric Exclusivity – incentive)</li>
<li>2002, Best Pharmaceuticals for Children Act(BPCA) (incentive)</li>
<li>2003, Pediatric Research Equity Act(PREA) (requirement)</li>
<li>2007, FDA Amendments Act(FDAAA) (reauthorized BPCA &amp; PREA)</li>
<li>2012, FDA Safety &amp; Innovation Act(FDASIA) (Permanently reauthorizes BPCA &amp; PREA)</li>
<li>2014: General Clinical Pharmacology Considerations for Pediatric Studies for Drugs and Biological Products <a href="https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm425885.pdf" class="uri">https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm425885.pdf</a></li>
</ul>
</div>
</div>
<div id="emea-1" class="section level2">
<h2><span class="header-section-number">2.2</span> EMEA</h2>
<p>EMEA</p>
<ul>
<li>2016, Reflection paper on extrapolation of efficacy and safety in paediatric medicine development <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2016/04/WC500204187.pdf" class="uri">http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2016/04/WC500204187.pdf</a></li>
<li>2016, Guideline on the qualification and reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/10/WC500213940.pdf" class="uri">http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/10/WC500213940.pdf</a></li>
<li>Guideline on the qualification and reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation <a href="http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211315.pdf" class="uri">http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211315.pdf</a></li>
</ul>
</div>
<div id="pmda-1" class="section level2">
<h2><span class="header-section-number">2.3</span> PMDA</h2>
<ul>
<li>영어 자료가 제한되어 의미있는 자료를 아직 찾지 못하였습니다.</li>
</ul>
</div>
</div>
<div id="ref" class="section level1">
<h1><span class="header-section-number">3</span> 참고문헌</h1>

<div id="refs" class="references">
<div id="ref-Mehrotra_2016">
<p>Mehrotra, N., A. Bhattaram, J. C. Earp, J. Florian, K. Krudys, J. E. Lee, J. Y. Lee, et al. 2016. “Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.” <em>Drug Metabolism and Disposition</em> 44 (7). American Society for Pharmacology &amp; Experimental Therapeutics (ASPET): 924–33. doi:<a href="https://doi.org/10.1124/dmd.116.069559">10.1124/dmd.116.069559</a>.</p>
</div>
<div id="ref-R-base">
<p>R Core Team. 2017. <em>R: A Language and Environment for Statistical Computing</em>. Vienna, Austria: R Foundation for Statistical Computing. <a href="https://www.R-project.org/" class="uri">https://www.R-project.org/</a>.</p>
</div>
</div>
</div>
            </section>

          </div>
        </div>
      </div>


    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/lunr.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"google": false,
"weibo": false,
"instapper": false,
"vk": false,
"all": ["facebook", "google", "twitter", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": null,
"text": null
},
"download": null,
"toc": {
"collapse": "subsection"
}
});
});
</script>

</body>

</html>
